GPC1 and pancreatic neoplasm: In contrast, other studies have failed to confirm the diagnostic value of GPC1 alone in pancreatic cancer (110), highlighting the need for the combination of GPC1 with other biomarkers to increase diagnosis accuracy (111, 112).